CONTRIBUTION OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN HOST-DEFENSE MECHANISM AGAINST CRYPTOCOCCUS-NEOFORMANS

Citation
K. Kawakami et al., CONTRIBUTION OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN HOST-DEFENSE MECHANISM AGAINST CRYPTOCOCCUS-NEOFORMANS, Clinical and experimental immunology, 106(3), 1996, pp. 468-474
Citations number
45
Categorie Soggetti
Immunology
ISSN journal
00099104
Volume
106
Issue
3
Year of publication
1996
Pages
468 - 474
Database
ISI
SICI code
0009-9104(1996)106:3<468:COT(IH>2.0.ZU;2-T
Abstract
We investigated the role of TNF-alpha in the host defence mechanism ag ainst infection with a virulent strain of Cryptococcus neoformans. Adm inistration of exogenous recombinant human TNF-alpha significantly pro longed the survival time of mice infected by intratracheal instillatio n of the organism. Surprisingly, neutralizing MoAb to murine TNF-alpha did not shorten their survival time, a finding inconsistent with prev ious results. To investigate the cause of this inconsistency, we exami ned the production of TNF-alpha in the lungs of infected mice. During the course of cryptococcosis, there was little or no generation of TNF -alpha mRNA in the lung. This might be partly due to a direct inhibito ry action of the fungal microorganism on TNF-alpha production by macro phages. In vitro production of TNF-alpha by murine interferon-gamma (I FN-gamma)- and lipopolysaccharide (LPS)-stimulated macrophages was str ongly inhibited by co-culturing with the whole yeast cells. In contras t, administration of recombinant murine IL-12 markedly induced TNF-alp ha production and the neutralizing anti-TNF-alpha MoAb strongly blocke d IL-12-induced protection of mice against cryptococcal infection. The se results indicate that endogenously synthesized TNF-alpha has the po tential to contribute to the elimination of C. neoformans and partly m ediates the protective effect of IL-12.